← FDA Drug Approvals (Drugs@FDA)

YUTREPIA

NDA · New Drug Application · Sponsor: LIQUIDIA TECH · Approved 2025-05-23

Drug application

FDA Application #

NDA213005

Application type

New Drug Application

Brand name

YUTREPIA

Generic name

TREPROSTINIL

Active ingredients

TREPROSTINIL SODIUM

Dosage form

POWDER

Route

INHALATION

Marketing status

Prescription

Sponsor

LIQUIDIA TECH

Manufacturer

Liquidia Technologies, Inc.

First approval

2025-05-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown